the key take away is - have a look at who is doing the DD. this is significant progress in my opinion. the life sciences team at KYOCERA have been given a mandate and a choice and they have chosen Leo and RGS.
yes they maybe getting a good deal, but to a company as large as Kyocera have plenty of cash, it's more reputation than the $$$, they are diversifying into an area they see growth, they have a clear strategy and RGS will be going along for the ride.
this is a bolt on acquisition if I ever saw one, it just comes down to price. I reckon that price will be ~$1.00
Leo is adamant RGS have superior technology in the market, next deal Leo signs will be reflected in the upfront!
Ann: Kyocera completes Progenza Due Diligence, page-11
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CMB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.772M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1267251 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 746300 | 6 |
View Market Depth
| Last trade - 16.12pm 03/07/2024 (20 minute delay) ? |
| CMB (ASX) Chart |
Day chart unavailable